Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Kui Qu

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Science Signaling|March 22, 2018
Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent mannerHong Zheng, Wen-Mei Yu, Ronald R Waclaw, et al.
Journal of Medicinal Chemistry|August 21, 2013
Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)Wei Liu, Bing Yu, Gang Xu, et al.
The Journal of Experimental Medicine|September 21, 2011
Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cellsDan Xu, Xia Liu, Wen-Mei Yu, et al.
Leukemia Research|October 27, 2016
Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosineHimalee S Sabnis, Heath L Bradley, Shweta Tripathi, et al.
Molecular and Cellular Biology|October 12, 2011
A critical role of mitochondrial phosphatase Ptpmt1 in embryogenesis reveals a mitochondrial metabolic stress-induced differentiation checkpoint in embryonic stem cellsJinhua Shen, Xia Liu, Wen-Mei Yu, et al.
Blood Advances|September 23, 2021
JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1βYuhan Yan, Lei Dong, Chao Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2016
Gain-of-function mutations of Ptpn11 (Shp2) cause aberrant mitosis and increase susceptibility to DNA damage-induced malignanciesXia Liu, Hong Zheng, Xiaobo Li, et al.
Molecular and Cellular Biology|April 25, 2002
Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 inductionRandy Shen, Ying-Bin Ouyang, Cheng-Kui Qu, et al.
Blood|July 24, 2010
A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cellsDan Xu, Siying Wang, Wen-Mei Yu, et al.
Cellular Signalling|June 13, 2006
Shp-2 tyrosine phosphatase is required for hepatocyte growth factor-induced activation of sphingosine kinase and migration in embryonic fibroblastsHai-Feng Duan, Cheng-Kui Qu, Qun-Wei Zhang, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Science Signaling|March 22, 2018
Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent mannerHong Zheng, Wen-Mei Yu, Ronald R Waclaw, et al.
Journal of Medicinal Chemistry|August 21, 2013
Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)Wei Liu, Bing Yu, Gang Xu, et al.
The Journal of Experimental Medicine|September 21, 2011
Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cellsDan Xu, Xia Liu, Wen-Mei Yu, et al.
Leukemia Research|October 27, 2016
Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosineHimalee S Sabnis, Heath L Bradley, Shweta Tripathi, et al.
Molecular and Cellular Biology|October 12, 2011
A critical role of mitochondrial phosphatase Ptpmt1 in embryogenesis reveals a mitochondrial metabolic stress-induced differentiation checkpoint in embryonic stem cellsJinhua Shen, Xia Liu, Wen-Mei Yu, et al.
Blood Advances|September 23, 2021
JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1βYuhan Yan, Lei Dong, Chao Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2016
Gain-of-function mutations of Ptpn11 (Shp2) cause aberrant mitosis and increase susceptibility to DNA damage-induced malignanciesXia Liu, Hong Zheng, Xiaobo Li, et al.
Molecular and Cellular Biology|April 25, 2002
Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 inductionRandy Shen, Ying-Bin Ouyang, Cheng-Kui Qu, et al.
Blood|July 24, 2010
A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cellsDan Xu, Siying Wang, Wen-Mei Yu, et al.
Cellular Signalling|June 13, 2006
Shp-2 tyrosine phosphatase is required for hepatocyte growth factor-induced activation of sphingosine kinase and migration in embryonic fibroblastsHai-Feng Duan, Cheng-Kui Qu, Qun-Wei Zhang, et al.
Pageof 9